News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Doyle Anthony
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
12/21/2022 |
4
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns:
| Granted 34,000 shares
@ $0 Granted 158,500 options to buy
@ $10.63, valued at
$1.7M
|
|
12/19/2022 |
4
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns:
| Sold 5,700 shares
@ $10.9, valued at
$62.1k
|
|
12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/24/2021 |
4
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns:
| Bought 35,258 shares
@ $12.48, valued at
$440k
|
|
12/17/2020 |
4
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns:
| Granted 332,500 options to buy
@ $8.31, valued at
$2.8M
|
|
08/12/2020 |
4
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns:
| Bought 54,000 shares
@ $4.08, valued at
$220.3k
|
|
05/04/2020 |
4
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns:
| Granted 600,000 options to buy
@ $3.91, valued at
$2.3M
|
|
|
|